Freya Meds vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Freya Meds
Best for patients wanting dietitian-supported compounded GLP-1 programsStarting at $250/mo
NovoCare Pharmacy
Best for branded Wegovy at the lowest manufacturer-direct self-pay priceStarting at $199/mo
Side-by-Side Comparison
| Feature | Freya Meds | NovoCare Pharmacy |
|---|---|---|
| Overall Score | 7.0/10 | ✓8.7/10 |
| Starting Price | $250/mo | ✓$199/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.4 ★ /5 |
| Features | 4 features | ✓5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Freya Meds
Pros
- ✓Pure GLP-1 specialist — not a multi-category telehealth
- ✓Price includes unlimited doctor consultations, monthly group calls, and dietitian consultation
- ✓Both semaglutide and tirzepatide available
- ✓Multi-month discount on quarterly billing
- ✓Claims 450,000+ enrolled
Cons
- ✗No visible LegitScript or PCAB accreditation
- ✗Pricing is above average ($250–$390/mo) compared to competitors
- ✗Compounded only — no brand-name options
- ✗Specific state exclusions not disclosed
NovoCare Pharmacy
Pros
- ✓First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
- ✓$199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
- ✓$349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
- ✓Ships to all 50 states; no telehealth-platform middleman fees
- ✓Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
- ✓Insurance-billing path also available via the standard NovoCare savings program
Cons
- ✗Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
- ✗Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
- ✗$199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
- ✗No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
- ✗Manufacturer-set pricing can change at any time
Our Verdict
NovoCare Pharmacy edges out Freya Meds with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Freya Meds remains a solid alternative, especially if you're looking for patients wanting dietitian-supported compounded GLP-1 programs.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Freya Meds and NovoCare Pharmacy head-to-heads in the same category.
- Freya Meds vs CoreAge Rx
- Freya Meds vs TrimRx
- Freya Meds vs Amazon One Medical
- NovoCare Pharmacy vs Vytora Health
- NovoCare Pharmacy vs Enhance MD
- NovoCare Pharmacy vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.